Business Insider
My Markets Watchlist
Markets Stocks

agilon health inc Registered Shs Stock , AGL

2.18 -0.04 -1.58%
03:59:59 PM BTT
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar

On Wednesday 06/25/2025 the closing price of the agilon health inc Registered Shs share was $2.18 on BTT. Compared to the opening price on Wednesday 06/25/2025 on BTT of $2.23, this is a drop of 2.30%. agilon health inc Registered Shs's market capitalization is $716.29 M by 413.95 M shares outstanding.

agilon health Stock Snapshot

2.15
Bid
50.00
Bid Size
2.23
Ask
60.00
Ask Size
6/25/2025
Date
3:59 PM
Time
54,895.00
Volume
2.21
Prev. Close
2.23
Open
889.38 M
Market Cap in USD
413.95 M
Number of Shares
413.95 M
Total Number of Shares
2.14
Day Low
2.23
Day High
2.18
1.51
52 Week Low
7.73
52 Week High
2.18
0.00
Dividend in USD
0.00
Dividend Yield
73.04
Free Float in %
-0.63
EPS in USD
1.14
Book Value per Share in USD
-0.14
Cash Flow per Share in USD

Historical Prices for agilon health

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

agilon health Analyst Data

Total Analysts: 26
Buy Ratings: 16 Neutral Ratings: 8 Sell Ratings: 2
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 3.00 Median: 10.62 Highest: 28.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

agilon health Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price
05/13/25 Wells Fargo & Co
Maintained Buy $5
05/08/25 Barclays Capital
Maintained Sell $3
05/08/25 Goldman Sachs
Maintained Hold $5
04/28/25 JMP Securities LLC
Maintained Hold
04/25/25 Citigroup Corp.
Upgraded to Buy $5
04/15/25 Baird Patrick & Co
Maintained Hold $5
04/08/25 Bernstein
Upgraded to Buy $8.5
03/21/25 Needham & Company, LLC
Maintained Hold
02/26/25 RBC Capital Markets
Maintained Buy $3.5
02/26/25 Stifel, Nicolaus & Co., Inc.
Maintained Buy $3
02/26/25 Needham & Company, LLC
Maintained Hold
07/09/24 Evercore
Maintained Hold $7
05/30/24 Baird Patrick & Co
Maintained Hold $6
05/01/24 Stifel, Nicolaus & Co., Inc.
Maintained Buy $7
04/22/24 Citigroup Corp.
Maintained Hold $6
03/06/24 Barclays Capital
Maintained Sell $5
02/29/24 The Benchmark Company
Maintained Buy $9
02/28/24 Evercore
Maintained Hold $6
02/28/24 RBC Capital Markets
Maintained Buy $8
02/22/24 Stifel, Nicolaus & Co., Inc.
Maintained Buy $9
01/08/24 Wolfe Research
Downgraded to Hold
01/05/24 J.P. Morgan
Downgraded to Hold $9
12/11/23 Goldman Sachs
Downgraded to Hold
12/06/23 JMP Securities LLC
Maintained Buy $18
11/21/23 Deutsche Bank
Downgraded to Hold $12
11/15/23 The Benchmark Company
Maintained Buy $22
11/13/23 Wells Fargo & Co
Maintained Buy $16
11/09/23 Goldman Sachs
Maintained Buy $22
11/03/23 RBC Capital Markets
Maintained Buy $23
10/20/23 The Benchmark Company
Maintained Buy $28
08/15/23 Goldman Sachs
Maintained Buy $25

agilon health Estimates* in USD

  2025 2026 2027 2028 2029
Revenue 5,958 6,597 7,925 9,157 10,656
Dividend 0.00 0.00 0.00 - -
Dividend Yield (in %) 0.00 % 0.00 % 0.00 % - -
EPS -0.34 -0.22 -0.12 0.02 0.06
P/E Ratio -6.58 -9.87 -18.48 114.66 36.83
EBIT -177 -115 -66 -4 27
EBITDA -79 -23 38 127 165
Net Profit -142 -95 -46 23 27
Net Profit Adjusted -154 -111 -64 8 27
Pre-Tax Profit -171 -122 -66 13 34
Pre-Tax Profit Reported -171 -122 -66 13 34
EPS (Non-GAAP) ex. SOE -0.37 -0.24 -0.18 -0.09 0.00
EPS (GAAP) -0.37 -0.28 -0.15 -0.03 0.12
Gross Income 69 142 239 323 415
Cash Flow from Investing -4 18 -1 -20 -19
Cash Flow from Operations -83 -4 0 43 107
Cash Flow from Financing 0 0 0 0 0
Cash Flow per Share 0.03 0.02 0.10 - -
Free Cash Flow -97 -31 -18 14 72
Free Cash Flow per Share -0.18 -0.05 - - -
Book Value per Share 0.98 0.83 0.73 - -
Net Debt -192 -176 -185 -195 -298
Research & Development Exp. - - - - -
Capital Expenditure 20 22 20 22 16
Selling, General & Admin. Exp. 268 286 - - -
Shareholder’s Equity 386 333 275 279 470
Total Assets 1,699 1,807 2,046 2,367 2,951
  Previous Quarter
ending 03/31/25 		Current Quarter
ending 06/30/25 		Next Quarter
ending 09/30/25 		Current Year
ending 12/31/25 		Next Year
ending 12/31/26
Earnings Estimates
No. of Analysts - 18 18 20 20
Average Estimate - -0.104 USD -0.101 USD -0.336 USD -0.224 USD
Year Ago - -0.075 USD -0.283 USD -0.612 USD -
Publish Date - 7/31/2025 10/30/2025 - -
Revenue Estimates
No. of Analysts - 17 17 19 19
Average Estimate - 1,472 USD 1,465 USD 5,958 USD 6,597 USD
Year Ago - 1,483 USD 1,451 USD 6,061 USD -
Publish Date - 7/31/2025 10/30/2025 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

2024 2023 2022 2021 2020 2019
Sales 6,060.53 4,316.36 2,708.21 1,833.56 1,218.33 794.41
Change of sales in % 40.41 59.38 47.70 50.50 53.36 -
Gross profit on sales -19.62 53.63 98.51 61.87 80.62 16.26
Gross profit on sales change in % - -45.56 59.23 -23.26 395.87 -
Operating income -283.96 -231.95 -117.96 -381.09 -56.67 -106.57
Operating income change in % -22.42 -96.63 69.05 -572.44 46.82 -
Income before tax -248.83 -194.46 -105.69 -404.60 -62.34 -114.69
Income before tax change in % -27.96 -83.99 73.88 -548.99 45.64 -
Income after tax -250.33 -195.05 -107.02 -405.18 -63.21 -114.30
Income after tax change in % -28.34 -82.26 73.59 -541.03 44.70 -

Balance Sheet in Mio. USD

2024 2023 2022 2021 2020 2019
Total liabilities 1,263.03 1,079.85 656.86 494.66 731.09 634.82
Long-term liabilities per share 0.27 0.25 0.30 0.34 0.40 0.39
Equity 470.95 661.02 1,040.61 1,091.60 -284.73 -232.03
Equity change in % -28.84 -36.44 -4.64 - -22.71 -
Balance sheet total 1,733.98 1,740.87 1,697.47 1,586.25 446.36 402.79
Balance sheet total change in % -0.40 2.56 7.01 255.37 10.82 -

Key Data in USD

2024 2023 2022 2021 2020 2019
Sales per share 14.75 10.56 6.64 4.58 3.12 2.03
P/E ratio (year end quote, basic EPS) - - - - - -
P/E ratio (year end quote, diluted EPS) - - - - - -
Dividend yield in % 0.00 0.00 0.00 0.00 - -
Equity ratio in % 27.16 37.97 61.30 68.82 -63.79 -57.60
Debt ratio in % 72.84 62.03 38.70 31.18 163.79 157.60

agilon health Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
Schwaneke Jeffrey A. 05/27/2025 9,331.00 1,121,221.00 2.35 Sell No
Wulf John William 05/27/2025 78,724.00 284,857.00 n/a Buy No
McLoughlin Karen 05/27/2025 78,724.00 151,890.00 n/a Buy No
MCKENZIE DIANA 05/27/2025 78,724.00 137,543.00 n/a Buy No
Battaglia Silvana 05/27/2025 78,724.00 144,868.00 n/a Buy No
Mansukani Sharad 05/27/2025 78,724.00 1,352,757.00 n/a Buy No
WILLIAMS RONALD A 05/27/2025 78,724.00 3,675,257.00 n/a Buy No
Gertsch Timothy 05/23/2025 193.00 115,158.00 2.22 Sell No
Zamore Denise 04/14/2025 5,490.00 444,040.00 5.53 Sell No
Sell Steven 04/14/2025 22,563.00 862,122.00 5.53 Sell No
Gertsch Timothy 04/14/2025 3,022.00 115,351.00 5.53 Sell No
Venkatachaliah Girish 04/14/2025 8,226.00 266,636.00 5.53 Sell No
Shaker Benjamin 04/14/2025 14,641.00 867,674.00 5.53 Sell No
Zamore Denise 04/13/2025 517.00 449,530.00 5.60 Sell No
Gertsch Timothy 04/13/2025 662.00 118,373.00 5.60 Sell No
Sell Steven 04/13/2025 7,898.00 884,685.00 5.60 Sell No
Venkatachaliah Girish 04/13/2025 2,808.00 274,862.00 5.60 Sell No
Shaker Benjamin 04/13/2025 3,665.00 882,315.00 5.60 Sell No
Shaker Benjamin 03/31/2025 428,922.00 885,980.00 n/a Buy No
Gertsch Timothy 03/31/2025 61,275.00 119,035.00 n/a Buy No
Venkatachaliah Girish 03/31/2025 122,550.00 277,670.00 n/a Buy No
Sell Steven 03/31/2025 551,471.00 906,781.00 n/a Buy No
Zamore Denise 03/31/2025 245,099.00 450,047.00 n/a Buy No
Schwaneke Jeffrey A. 03/31/2025 428,922.00 1,130,552.00 n/a Buy No
Shaker Benjamin 03/13/2025 4,143.00 457,058.00 4.05 Sell No

agilon health Dividend Calendar

Date Name Dividend *yield Currency
2024 agilon health inc Registered Shs 0.00 0.00 USD
2023 agilon health inc Registered Shs 0.00 0.00 USD
2022 agilon health inc Registered Shs 0.00 0.00 USD
2021 agilon health inc Registered Shs 0.00 0.00 USD
2020 agilon health inc Registered Shs - - USD
2019 agilon health inc Registered Shs - - USD
*Yield of the Respective Date

agilon health Calendar

Event Estimate Info Date
Earnings Report -0.104 USD Q2 2025 Earnings Release 07/31/2025
Earnings Report -0.101 USD Q3 2025 Earnings Release 10/30/2025
Earnings Report -0.139 USD Q4 2025 Earnings Release 03/03/2026
Earnings Report 0.025 USD Q1 2026 Earnings Release 05/12/2026

agilon health Past Events

Event Actual EPS Info Date
Annual General Meeting -0.630 USD Annual General Meeting 05/28/2025
Earnings Report 0.030 USD Q1 2025 Earnings Release 05/06/2025
Earnings Report -0.260 USD Q4 2024 Earnings Release 02/25/2025
Earnings Report -0.290 USD Q3 2024 Earnings Release 11/07/2024
Earnings Report -0.070 USD Q2 2024 Earnings Release 08/06/2024
Annual General Meeting -0.640 USD Annual General Meeting 05/29/2024
Earnings Report -0.010 USD Q1 2024 Earnings Release 05/07/2024
Earnings Report -0.570 USD Q4 2023 Earnings Release 02/27/2024
Earnings Report -0.080 USD Q3 2023 Earnings Release 11/02/2023
Earnings Report -0.040 USD Q2 2023 Earnings Release 08/03/2023
Annual General Meeting -0.260 USD Annual General Meeting 05/24/2023
Earnings Report 0.040 USD Q1 2023 Earnings Release 05/09/2023
Earnings Report -0.140 USD Q4 2022 Earnings Release 03/01/2023
Earnings Report -0.070 USD Q3 2022 Earnings Release 11/03/2022
Earnings Report -0.050 USD Q2 2022 Earnings Release 08/04/2022
Annual General Meeting -1.090 USD Annual General Meeting 05/24/2022
Earnings Report 0.000 USD Q1 2022 Earnings Release 05/05/2022
Earnings Report -0.140 USD Q4 2021 Earnings Release 03/03/2022

agilon health Profile

Agilon Health, Inc. engages in providing healthcare services. It also provides the technology, people, capital, process, and access to a peer network of primary care physicians. The company was founded by Ronald A. Williams and Veeral Desai in 2016 and is headquartered in Westerville, OH.
OSZAR »